NDC properties for NDC 9 60505-1005
NDC item 60505100501
| NDC 9 | 60505-1005 |
|---|---|
| NDC 10 | 60505-1005-1 |
| NDC Item | 60505100501 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-1) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA204936 |
| FDA SPL set id | 788504 |
| Labeler | Apotex Corp |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-05-31 |
| Marketing effective time low | 2017-11-27 |
| Marketing status | COMPLETED |
NDC item 60505100504
| NDC 9 | 60505-1005 |
|---|---|
| NDC 10 | 60505-1005-4 |
| NDC Item | 60505100504 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (60505-1005-4) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA204936 |
| FDA SPL set id | 788504 |
| Labeler | Apotex Corp |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-05-31 |
| Marketing effective time low | 2017-11-27 |
| Marketing status | COMPLETED |
NDC item 68682004525
| NDC 9 | 68682-045 |
|---|---|
| NDC 10 | 68682-045-25 |
| NDC Item | 68682004525 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 448355 |
| Labeler | Oceanside Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-05-30 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021516 |
NDC item 68682004550
| NDC 9 | 68682-045 |
|---|---|
| NDC 10 | 68682-045-50 |
| NDC Item | 68682004550 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (68682-045-50) / 5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 448355 |
| Labeler | Oceanside Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-05-30 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021516 |
NDC item 70069051601
| NDC 9 | 70069-516 |
|---|---|
| NDC 10 | 70069-516-01 |
| NDC Item | 70069051601 |
| packaging | 1 BOTTLE in 1 CARTON (70069-516-01) / 2.5 mL in 1 BOTTLE |
| ANDA | ANDA216653 |
| FDA SPL set id | 796359 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-09 |
| Marketing status | ACTIVE |
NDC item 70069051701
| NDC 9 | 70069-517 |
|---|---|
| NDC 10 | 70069-517-01 |
| NDC Item | 70069051701 |
| packaging | 1 BOTTLE in 1 CARTON (70069-517-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA216653 |
| FDA SPL set id | 796359 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-09 |
| Marketing status | ACTIVE |
NDC item 82260004505
| NDC 9 | 82260-045 |
|---|---|
| NDC 10 | 82260-045-05 |
| NDC Item | 82260004505 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-05) / 5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 826867 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021516 |
NDC item 82260004525
| NDC 9 | 82260-045 |
|---|---|
| NDC 10 | 82260-045-25 |
| NDC Item | 82260004525 |
| packaging | 1 BOTTLE, DROPPER in 1 CARTON (82260-045-25) / 2.5 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 826867 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-06-23 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021516 |